Using a machine learning approach for the analysis of gene expression profiles, Mer et al. identified two different subtypes within NPM1-mut AML patients, one labeled as primitive and the other one as committed, based on the respective presence or absence of a stem cell signature [24]. The gene discussed is NPM1; the disease is acute myeloid leukemia.